Related Experiment Video

Updated: Aug 11, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Abnormal response to IL-5 in B-cell chronic lymphocytic leukemia

T G Hayes1, X L Tan, A B Moseley

  • 1Department of Medicine, Baylor College of Medicine, Houston, Texas.

Leukemia Research
|September 1, 1993
PubMed

Insights

B-cell chronic lymphocytic leukemia (B-CLL) involves arrested B-lymphocyte development. B-CLL cells show impaired response to Interleukin-5 (IL-5), suggesting a role in disease pathogenesis.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • B-cell chronic lymphocytic leukemia (B-CLL) is characterized by the accumulation of malignant B-lymphocytes arrested at specific developmental stages.
  • Interleukins are critical signaling molecules that regulate B-cell proliferation, differentiation, and survival.

Purpose of the Study:

  • To investigate the functional response of B-CLL lymphocytes to key interleukins, specifically Interleukin-5 (IL-5).
  • To determine if impaired IL-5 signaling contributes to the developmental arrest observed in B-CLL pathogenesis.

Main Methods:

  • Purified B-lymphocytes were isolated from both B-CLL patients and healthy controls.
  • Cells were stimulated with mitogenic stimuli (MCAT or SAC) in the presence or absence of recombinant human Interleukin-5 (rhIL-5) or Interleukin-2 (rhIL-2).
  • Proliferation and differentiation, assessed by IgM production, were measured to evaluate cellular responses.

Main Results:

  • Control B-lymphocytes exhibited a significant increase in IgM production upon stimulation with MCAT and rhIL-5.
  • In contrast, B-CLL lymphocytes showed a markedly diminished response to rhIL-5, with only 1 out of 10 patients demonstrating increased IgM production.
  • No significant differences were observed in responses to rhIL-2.

Conclusions:

  • The impaired responsiveness of B-CLL cells to IL-5 suggests a functional defect in B-cell differentiation pathways.
  • This lack of IL-5 signaling may be a contributing factor to the arrested B-lymphocyte development characteristic of B-CLL.
  • Targeting IL-5 signaling could represent a potential therapeutic strategy for B-CLL.

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...